Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation With an Open-Label Expansion
Clinical trial NCT02070744 · COMPLETED
Trial details
- NCT number
- NCT02070744
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2016-05-27
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.